Congress approved the fiscal year 2022 omnibus spending package on March 11. It included great news for the childhood cancer community: the STAR Act will receive $30M and the Childhood Cancer Data Initiative will receive $50M. There were several other specifics in the budget important for our community: NIH/HHS Funding
- The STAR Act received $30M and CCDI received $50M for FY22 – full funding for both programs!
- NIH received $45B for FY22, an increase of $2.25B over FY21.
- NCI received $6.9B for FY22, an increase of $353M over FY21. This also includes $194M for the Cancer Moonshot.
- The omnibus provided $1B to create the Advanced Research Projects Agency for Health (ARPA-H) within the HHS Office of the Secretary. Funding is available for 3 years.
- The Gabriella Miller Kids First Research Act received $12.6M for FY22.
DOD Funding
- The Peer Review Cancer Research Program (PRCRP) received $130M for FY22, a $15M increase over FY21. The PRCRP also includes each research category the Alliance requested in our FY22 DOD letter: pediatric, adolescent and young adult cancers; pediatric brain tumors; neuroblastoma; sarcoma; germ cell cancers; blood cancers; lymphoma; and thyroid cancer.
